elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33466527-BE14D8F0-2B34-4986-9F9B-98943BDDB0D2
Q33466527-BE14D8F0-2B34-4986-9F9B-98943BDDB0D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33466527-BE14D8F0-2B34-4986-9F9B-98943BDDB0D2
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
P2860
Q33466527-BE14D8F0-2B34-4986-9F9B-98943BDDB0D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33466527-BE14D8F0-2B34-4986-9F9B-98943BDDB0D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f606c56fd1d574b164e31968cb93d3d62fd9de73
P2860
American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.